{"id":"W2598181800","doi":"10.1200/jco.2012.30.15_suppl.5019","title":"A phase II study of RO4929097 (RO), a gamma-secretase inhibitor, in advanced platinum (Pt)-resistant (R) ovarian cancer (OC): A study of the PMH, Chicago, and California phase II consortia.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Credit Valley Hospital; University of Toronto; University Health Network; Cancer Care Ontario; Juravinski Cancer Centre; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Progression-free survival; Cancer; Oncology; Progressive disease; Adverse effect; Serous fluid; Chemotherapy; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001940619,0.001166097,0.001693778,0.0005319037,0.0004218983,0.0007730864,0.0009399287,0.001277431,0.003686441],"category_scores_gemma":[0.0009572953,0.000650743,0.0008115182,0.0005212923,0.000996116,0.0007704954,0.0003180429,0.002188593,0.0008081506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008381291,"about_ca_system_score_gemma":0.001719727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001251528,"about_ca_topic_score_gemma":0.003048171,"domain_scores_codex":[0.9994999,0.0002741879,0.00002355285,0.00009132168,0.00004697239,0.00006402614],"domain_scores_gemma":[0.9990907,0.0001852717,0.0001538501,0.00009934951,0.00005584777,0.0004149199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5862291,0.1423159,0.01734614,0.001272272,0.001466152,0.00067726,0.0007273617,0.003755226,0.09177574,0.0005577863,0.007165175,0.1467119],"study_design_scores_gemma":[0.4445215,0.5307628,0.01583337,0.00003836055,0.0003421622,0.0005064392,0.00007739287,0.0010259,0.003243819,0.000160832,0.003459528,0.00002795432],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895478,0.002052218,0.0008058853,0.0003689152,0.00007591699,0.004393173,0.0009879431,0.00008469605,0.001683294],"genre_scores_gemma":[0.9818309,0.002689826,0.002800742,0.0008508653,0.0001629393,0.005091332,0.00296478,0.00004620067,0.003562505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003686441,"threshold_uncertainty_score":0.01233232,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09066157760645395,"score_gpt":0.4651790089251341,"score_spread":0.3745174313186802,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}